IMV Inc.
IMV Inc. (IMVIF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IMVIF · as of Jun 8, 2026
Key Statistics
Explore IMV Inc. Data
imvif stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
imvif competitorsIMVIF
ADYX
ATRX
BIMI
CFRXQ
DMKPQStock Performance
Full HistoryAbout IMV Inc.
IMV Inc. is a biopharmaceutical firm focused on immuno-oncology, currently in the clinical development stage. The company leverages its proprietary DPX immune-modulating platform to create a diverse r…
what is imv inc. · imvif stock overview · imv inc. company profile · who is imv inc. ceo · imvif OTC · imv inc. headquarters · imv inc. business segments
About Stock Overview & Key Data
IMV Inc. (IMVIF) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 8, 2013. As of the latest trading session, IMVIF stock price is $0.00, with a market capitalization of $23,423. The stock has returned +1900.00% over the past 12 months and +19900.00% year-to-date.
In fiscal year 2022, IMV Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IMV Inc. (IMVIF) stock price is $0.00. The stock is traded on OTC under the ticker symbol IMVIF. The 52-week range is $0.00 – $0.01.